Different dosage regimens of Eptinezumab for the treatment of migraine: a meta-analysis from randomized controlled trials.
J Headache Pain
; 22(1): 10, 2021 Mar 06.
Article
in En
| MEDLINE
| ID: mdl-33676408
Full text:
1
Database:
MEDLINE
Main subject:
Antibodies, Monoclonal, Humanized
/
Migraine Disorders
Type of study:
Clinical_trials
/
Systematic_reviews
Limits:
Humans
Language:
En
Journal:
J Headache Pain
Journal subject:
MEDICINA INTERNA
/
NEUROLOGIA
/
PSICOFISIOLOGIA
Year:
2021
Type:
Article
Affiliation country:
China